ECGS yields 2000.00% · PFE yields 6.13%● Live data
📍 ECGS pulled ahead of the other in Year 1
Combined, ECGS + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ECGS + PFE for your $10,000?
Falcon Technologies, Inc. provides various design-build infrastructure services. The company offers telecommunications and data infrastructure services, which include communications infrastructure services to commercial, government, and other business enterprises. It also provides engineering services, program management, construction, installation and maintenance services, premise wiring services, tower and radio infrastructure services, and technology implementation and integration services, as well as a portfolio of infrastructure engineering and construction services. In addition, it offers design/build, installation, and maintenance services for electrical systems in factories, offices, healthcare facilities, government bases, and installations; and cell-phone relay towers, as well as sells electrical equipment, such as light fixtures, switchgear/panels, and fire alarm and control systems. Further, the company undertakes fire protection contracts in Northern California to provides layout and installation of various types of fire sprinkler systems, including wet and dry pipe, pre-action, in-rack, and fire pump systems in various commercial and industrial applications in new corporate headquarters, shopping centers, multi-tenant buildings, hospitals, nursing facilities, schools, and churches. Additionally, it offers emergency fire protection services with a fleet of approximately 25 service trucks. The company serves commercial builders/developers, government contractors, federal and state governments, education sector, and city/county. Falcon Technologies, Inc. is based in Rancho Cordova, California.
Full ECGS Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.